Filing Details

Accession Number:
0001127602-22-012413
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-04-22 16:18:40
Reporting Period:
2022-04-20
Accepted Time:
2022-04-22 16:18:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1520262 Alkermes Plc. ALKS Pharmaceutical Preparations (2834) 981007018
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1842348 Curtis Blair Jackson 852 Winter St.
Waltham MA 02451
Evp, Chief Operating Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2022-04-20 49,999 $16.55 137,914 No 4 M Direct
Ordinary Shares Disposition 2022-04-20 49,999 $29.61 87,915 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Employee Stock Option (Right to Buy) Disposition 2022-04-20 49,999 $0.00 49,999 $16.55
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2022-05-21 No 4 M Direct
Footnotes
  1. This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  2. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $29.50 to $29.76. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request.
  4. These options are fully vested in accordance with their terms.